Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses (Q40127387)

17 September 2017

Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses (English)

1 reference

17 September 2017

Tomoya Nagata

1

1 reference

17 September 2017

Toshiaki Toyota

2

1 reference

17 September 2017

Hirohito Ishigaki

3

1 reference

17 September 2017

Toru Ichihashi

4

1 reference

17 September 2017

Kiichi Kajino

5

1 reference

17 September 2017

Yoshitaka Kashima

6

1 reference

17 September 2017

Yasushi Itoh

7

1 reference

17 September 2017

Masahito Mori

8

1 reference

17 September 2017

Hiroshi Oda

9

1 reference

17 September 2017

Hiroyuki Yamamura

10

1 reference

17 September 2017

Maiko Taneichi

11

1 reference

17 September 2017

Tetsuya Uchida

12

1 reference

17 September 2017

Kazumasa Ogasawara

13

1 reference

17 September 2017

language of work or name

English

0 references

publication date

20 April 2007

1 reference

17 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

17 September 2017

25

1 reference

17 September 2017

4914-4921

1 reference

17 September 2017

26

1 reference

The protective efficacy of a liposomal encapsulated 30 kDa secretory protein of Mycobacterium tuberculosis H37Ra against tuberculosis in mice

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Immunogenicity and protectivity of a new liposomal hepatitis A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Liposomes as carriers of antigens and adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Ovalbumin-liposome conjugate induces IgG but not IgE antibody production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Surface-linked liposomal antigen induces ige-selective unresponsiveness regardless of the lipid components of liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Suppression of specific IgE antibody responses by liposome-conjugated ovalbumin in mice sensitized with ovalbumin via the respiratory tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

synthetic peptide vaccines effective in preventing virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Antigen chemically coupled to the surface of liposomes are cross-presented to CD8+ T cells and induce potent antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Antigen-specific, IgE-selective unresponsiveness induced by antigen-liposome conjugates. Comparison of four different conjugation methods for the coupling of antigen to liposome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Phenotypic stability of mature dendritic cells tuned by TLR or CD40 to control the efficiency of cytotoxic T cell priming.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Immunological adjuvants: a role for liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Liposomes as immunoadjuvants and vaccine carriers: antigen entrapment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Liposomes as carriers for vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Liposome-mediated DNA vaccination: the effect of vesicle composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Alteration of lipid composition modulates Fc epsilon RI signaling in RBL-2H3 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Lipid composition determines the effects of arbutin on the stability of membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Differential activation of cell-mediated immune functions by encapsulated and surface-linked liposomal antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Targeting the innate immune response with improved vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Adverse reactions to Japanese encephalitis vaccine in travellers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.010

10.1016/J.VACCINE.2007.04.010

7 January 2021

Identifiers

DOI

1 reference

17 September 2017

1 reference